The Delaware Supreme Court's revival of a multibillion-dollar stockholder derivative suit against drug giant AmerisourceBergen Corp. has heightened court concern for assuring fiduciary loyalty and care compliance among state-chartered companies caught up in lawbreaking claims elsewhere, experts told Law360.